基于图深度学习的组织病理学图像预测卵巢癌患者预后和治疗反应:一项多中心回顾性研究
该多中心回顾性研究开发了基于图深度学习的卵巢癌数字病理指数(OCDPI),利用H&E染色全切片图像预测预后和辅助治疗反应。OCDPI在TCGA-OV队列开发,并在PLCO和HMUCH两个独立队列外部验证,显示对总生存的预后能力(PLCO HR 1.916,95%CI 1.380-2.660,P<0.001;HMUCH HR 2.796,95%CI 1.404-5.568,P=0.0022)。低OCDPI患者辅助治疗后生存获益更好、复发率更低,OCDPI为独立预后因素。
要点
- OCDPI在PLCO队列预测总生存HR 1.916(95%CI 1.380-2.660,P<0.001)。
- OCDPI在HMUCH队列预测总生存HR 2.796(95%CI 1.404-5.568,P=0.0022)。
- 低OCDPI患者辅助治疗后生存获益更好且复发率更低。
核心结论
- 多中心队列研究结果表明,OCDPI可能作为有价值且节省人力的工具,改善卵巢癌患者的预后和预测性临床决策。
研究设计与样本
- 多中心回顾性研究,使用TCGA-OV队列的福尔马林固定石蜡包埋全切片图像开发OCDPI,并在PLCO和HMUCH两个独立队列进行外部验证。
主要发现
- OCDPI对总生存的预后能力:PLCO队列HR 1.916(95%CI 1.380-2.660,log-rank检验P<0.001),HMUCH队列HR 2.796(95%CI 1.404-5.568,log-rank检验P=0.0022)。
- 低OCDPI患者接受辅助治疗后生存获益更好且复发率更低, compared to high OCDPI patients。
- 校正临床病理因素的多变量分析中,OCDPI在所有队列均被确定为独立预后因素(所有P<0.05)。
- OCDPI在低级别肿瘤或新鲜冷冻切片患者中表现良好,并能区分对辅助治疗敏感和不敏感的HRD缺陷或HRD完整患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ovarian cancer (OV) is a prevalent and deadly disease with high mortality rates. The development of accurate prognostic tools and personalized therapeutic strategies is crucial for improving patient outcomes. METHODS: A graph-based deep learning model, the Ovarian Cancer Digital Pathology Index (OCDPI), was introduced to predict prognosis and response to adjuvant therapy using hematoxylin and eosin (H&E)-stained whole-slide images (WSIs). The OCDPI was developed using formalin-fixed, paraffin-embedded (FFPE) WSIs from the TCGA-OV cohort, and was externally validated in two independent cohorts from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) and Harbin Medical University Cancer Hospital (HMUCH). RESULTS: The OCDPI showed prognostic ability for overall survival prediction in the PLCO (HR, 1.916; 95% CI, 1.380-2.660; log-rank test, P < 0.001) and HMUCH (HR, 2.796; 95% CI, 1.404-5.568; log-rank test, P = 0.0022) cohorts. Patients with low OCDPI experienced better survival benefits and lower recurrence rates following adjuvant therapy compared to those with high OCDPI. Multivariable analyses, adjusting for clinicopathological factors, consistently identified OCDPI as an independent prognostic factor across all cohorts (all P < 0.05). Furthermore, OCDPI performed well in patients with low-grade tumors or fresh-frozen slides, and could differentiate between HRD-deficient or HRD-intact patients with and without sensitivity to adjuvant therapy. CONCLUSION: The results from this multicenter cohort study indicate that the OCDPI may serve as a valuable and labor-saving tool to improve prognostic and predictive clinical decision-making in patients with OV.
引用
- Yang Z, Zhang Y, Zhuo L, et al. Prediction of prognosis and treatment response in ovarian cancer patients from histopathology images using graph deep learning: a multicenter retrospective study. Eur J Cancer. 2024. PMID: 38241820. doi:10.1016/j.ejca.2024.113532
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。